Does SEN-V and other non-A-E hepatotropic viruses contribute to the development and progression of non-alcoholic fatty liver disease?

Autor: Grubert Van Iderstine M; Section of Hepatology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Osiowy C; National Microbiology Laboratory, Winnipeg, Manitoba, Canada., Rumbolt C; Section of Hepatology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Zhang M; Section of Hepatology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Swidinsky K; National Microbiology Laboratory, Winnipeg, Manitoba, Canada., Kaita KDE; Section of Hepatology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Minuk GY; Section of Hepatology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: gerald.minuk@umanitoba.ca.
Jazyk: angličtina
Zdroj: Medical hypotheses [Med Hypotheses] 2020 Apr; Vol. 137, pp. 109528. Date of Electronic Publication: 2019 Dec 12.
DOI: 10.1016/j.mehy.2019.109528
Abstrakt: Approximately 10-20% of patients with non-alcoholic fatty liver disease (NAFLD) are at risk of progressing to cirrhosis. The cause of such progression is unclear. SEN-V is a hepatotropic virus that has been associated with more severe and advanced liver disease in patients with chronic hepatitis C virus infections. In this study we tested 32 NAFLD patients for evidence of SEN-V infection and correlated the results with histologic findings. The results of the study revealed similar disease severity and stage of progression in SEN-V positive and negative patients. Although not supportive of our hypothesis, the possibility that SEN-V and/or other non-A-E hepatotropic viruses contribute to the development and course of NAFLD is discussed.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2019 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE